BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 34400244)

  • 1. Stable Clostridioides difficile infection rates after the discontinuation of ultraviolet light for terminal disinfection at a tertiary care center, Iowa 2019-2020.
    Abosi OJ; Kobayashi T; Holley S; Kukla ME; Dains A; Alsuhaibani M; Marra AR; Jenn KE; Meacham H; Sheeler LL; Etienne W; Trannel A; Garringer J; Millard W; Diekema DJ; Edmond MB; Wellington M; Salinas JL
    Am J Infect Control; 2021 Dec; 49(12):1567-1568. PubMed ID: 34400244
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effectiveness of pulsed xenon ultraviolet disinfection for Clostridioides (Clostridium) difficile surface contamination in a Japanese hospital.
    Kitagawa H; Mori M; Hara T; Kashiyama S; Shigemoto N; Ohge H
    Am J Infect Control; 2021 Jan; 49(1):55-58. PubMed ID: 32485271
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of pulsed xenon ultraviolet light disinfection on healthcare-associated Clostridioides difficile rates in a tertiary care hospital.
    Attia F; Whitener C; Mincemoyer S; Houck J; Julian K
    Am J Infect Control; 2020 Sep; 48(9):1116-1118. PubMed ID: 31982216
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of no-touch ultraviolet light room disinfection systems on Clostridioides difficile infections.
    McMullen K; Guth RM; Wood H; Mueller C; Dunn G; Wade R; Siddiqui A; Dubberke ER; Woeltje KF; Warren DK
    Am J Infect Control; 2021 May; 49(5):646-648. PubMed ID: 32860846
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effectiveness of targeted enhanced terminal room disinfection on hospital-wide acquisition and infection with multidrug-resistant organisms and Clostridium difficile: a secondary analysis of a multicentre cluster randomised controlled trial with crossover design (BETR Disinfection).
    Anderson DJ; Moehring RW; Weber DJ; Lewis SS; Chen LF; Schwab JC; Becherer P; Blocker M; Triplett PF; Knelson LP; Lokhnygina Y; Rutala WA; Sexton DJ;
    Lancet Infect Dis; 2018 Aug; 18(8):845-853. PubMed ID: 29880301
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhanced terminal room disinfection and acquisition and infection caused by multidrug-resistant organisms and Clostridium difficile (the Benefits of Enhanced Terminal Room Disinfection study): a cluster-randomised, multicentre, crossover study.
    Anderson DJ; Chen LF; Weber DJ; Moehring RW; Lewis SS; Triplett PF; Blocker M; Becherer P; Schwab JC; Knelson LP; Lokhnygina Y; Rutala WA; Kanamori H; Gergen MF; Sexton DJ;
    Lancet; 2017 Feb; 389(10071):805-814. PubMed ID: 28104287
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effectiveness of ultraviolet disinfection in reducing hospital-acquired Clostridium difficile and vancomycin-resistant Enterococcus on a bone marrow transplant unit.
    Brite J; McMillen T; Robilotti E; Sun J; Chow HY; Stell F; Seo SK; McKenna D; Eagan J; Montecalvo M; Chen D; Sepkowitz K; Kamboj M
    Infect Control Hosp Epidemiol; 2018 Nov; 39(11):1301-1306. PubMed ID: 30226124
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chasing the rate: An interrupted time series analysis of interventions targeting reported hospital onset
    Doll ME; Zhao J; Kang L; Rittmann B; Alvarez M; Fleming M; Cooper K; Stevens MP; Bearman G
    Infect Control Hosp Epidemiol; 2020 Oct; 41(10):1142-1147. PubMed ID: 32493530
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Environmental Cleaning and Decontamination to Prevent Clostridioides difficile Infection in Health Care Settings: A Systematic Review.
    Schoyer E; Hall K
    J Patient Saf; 2020 Sep; 16(3S Suppl 1):S12-S15. PubMed ID: 32809996
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Portable Ultraviolet Light Surface-Disinfecting Devices for Prevention of Hospital-Acquired Infections: A Health Technology Assessment.
    Health Quality Ontario
    Ont Health Technol Assess Ser; 2018; 18(1):1-73. PubMed ID: 29487629
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of an automated multiple emitter whole-room ultraviolet-C disinfection system on hospital acquired infections: A quasi-experimental study.
    Steele M; Hurtado RR; Rychlik K; Bonebrake A; Bovee MC; O'Donnell A; Perryman J; Kociolek LK
    Am J Infect Control; 2021 Sep; 49(9):1200-1203. PubMed ID: 33774103
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ultraviolet-C Light Evaluation as Adjunct Disinfection to Remove Multidrug-Resistant Organisms.
    Rock C; Hsu YJ; Curless MS; Carroll KC; Ross Howard T; Carson KA; Cummings S; Anderson M; Milstone AM; Maragakis LL
    Clin Infect Dis; 2022 Aug; 75(1):35-40. PubMed ID: 34636853
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of ultraviolet-C light disinfection at terminal patient discharge on hospital-acquired infections in bone marrow transplant and oncology units.
    Murphy P; Kang L; Fleming M; Atkinson C; Pryor R; Cooper K; Godbout E; Stevens MP; Doll M; Bearman G
    Am J Infect Control; 2020 Jun; 48(6):705-707. PubMed ID: 31744632
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of an automated ultraviolet radiation device for decontamination of Clostridium difficile and other healthcare-associated pathogens in hospital rooms.
    Nerandzic MM; Cadnum JL; Pultz MJ; Donskey CJ
    BMC Infect Dis; 2010 Jul; 10():197. PubMed ID: 20615229
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A trial of pulsed xenon ultraviolet disinfection to reduce Clostridioides difficile infection.
    Sampathkumar P; Folkert C; Barth JE; Nation L; Benz M; Hesse A; Mielke Ms CL; Zaveleta KW
    Am J Infect Control; 2019 Apr; 47(4):406-408. PubMed ID: 30502111
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effectiveness of a combined UV-C and ozone treatment in reducing healthcare-associated infections in hospital facilities.
    Sottani C; Favorido Barraza G; Frigerio F; Corica G; Robustelli Della Cuna FS; Cottica D; Grignani E
    J Hosp Infect; 2023 Sep; 139():207-216. PubMed ID: 37478911
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Limited reduction in Clostridioides difficile and Methicillin-Resistant Staphylococcus aureus with the use of an aerosolized hydrogen peroxide disinfection system in tertiary health care facilities in Alberta, Canada.
    Gagnon H; Pokhrel A; Bush K; Cordoviz M; Ewashko T; Galetta F; Leal J
    Am J Infect Control; 2024 Apr; 52(4):410-418. PubMed ID: 37806387
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of an aerosolized hydrogen peroxide disinfection system for the reduction of Clostridioides difficile hospital infection rates over a 10 year period.
    Truitt CL; Runyan DA; Stern JJ; Tobin C; Goldwater W; Madsen R
    Am J Infect Control; 2022 Apr; 50(4):409-413. PubMed ID: 35307211
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of pulsed xenon ultraviolet disinfection of multidrug-resistant bacteria and Clostridioides difficile spores.
    Kitagawa H; Tadera K; Hara T; Kashiyama S; Mori M; Ohge H
    Infect Dis Health; 2020 Aug; 25(3):181-185. PubMed ID: 32284309
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of portable pulsed xenon ultraviolet light after terminal cleaning on hospital-associated Clostridium difficile infection in a community hospital.
    Levin J; Riley LS; Parrish C; English D; Ahn S
    Am J Infect Control; 2013 Aug; 41(8):746-8. PubMed ID: 23685092
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.